India’s Pharmexcil Revises Downward Drug Export Forecast
This article was originally published in PharmAsia News
India's drug-exporting promoter forecasts a 10 percent decline in the growth of pharmaceutical exports in the 2008-2009 period due to the global economic slowdown. The Pharmaceutical Export Promotion Council revised its previous forecast for exports for the period, at $8.97 billion, to just $8.25 billion. That translates to a 13.9 percent growth rate rather than 23.9 predicted earlier. Pharmexcil cited the tightened credit market as a major contributor to the revised prospects, with some developing countries having to cancel expansions of their health care programs. (Click here for more
You may also be interested in...
MUMBAI - Large consignments of drug exports from India routed through the European Union are being confiscated on allegations of violation of local European patent laws. As per the EU patent laws, such exports are also termed as counterfeit drugs, experts say
From efficacy endpoints to patient warehousing, US FDA advisors weigh in on vaccine development and regulatory review.
Several years ago, heart device giant Edwards Lifesciences realized it needed a new CAPA framework that shifts corrective and preventive action from a one-size-fits-all method to a more nuanced approach. See what Dan Buehner, director of quality engineering at Edwards Lifesciences, said about it here.